You are currently browsing the archives for 15 October 2017.
Displaying 1 entry.

Within a report performed by the Cancers and Leukemia Group B in advanced lung cancer.

.. CYFRA reliable marker for response to chemotherapy for NSCLC Researchers found that CYFRA and switch in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung malignancy in a report of 88 patients. Analysis offered in the April 2012 problem of the International Association for the analysis of Lung Cancer’s Journal of Thoracic Oncology implies that this marker can be used to determine whether or not an individual should continue a specific chemotherapy regimen. Within a report performed by the Cancers and Leukemia Group B in advanced lung cancer, serum CYFRA levels were measured at baseline and following the first routine of treatment. According to the study, higher baseline CYFRA concentrations portend even worse overall and failure free of charge survival.